ArticleFrontiers in cardiovascular medicine2022

Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.

Vincenzo Quagliariello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.